Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Origin Therapeutics Holdings Inc. (ORIG.CN)

Origin Therapeutics Holdings Inc. (ORIG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,414
  • Shares Outstanding, K 56,563
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,450 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.27
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $0.00 on 08/30/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.020 +25.00%
on 01/13/23
0.035 -28.57%
on 01/17/23
unch (unch)
since 01/03/23
3-Month
0.015 +66.67%
on 12/16/22
0.040 -37.50%
on 11/23/22
-0.005 (-16.67%)
since 11/03/22

Most Recent Stories

More News
UPDATE - Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma

Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively...

ORIG.CN : 0.025 (unch)

Business Summary

Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

See More

Key Turning Points

3rd Resistance Point 0.025
2nd Resistance Point 0.025
1st Resistance Point 0.025
Last Price 0.025
1st Support Level 0.025
2nd Support Level 0.025
3rd Support Level 0.025

See More

52-Week High 0.155
Fibonacci 61.8% 0.102
Fibonacci 50% 0.085
Fibonacci 38.2% 0.069
Last Price 0.025
52-Week Low 0.015

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar